• Ticagrelor monotherapy vs ticagrelor plus acetylsalicylic acid in patients with myocardial infarction treated medically

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    France
  • Safety and Pharmacodynamic Study of Subcutaneous RBD1119 in Adults with Coronary Artery Disease

    Not yet recruiting

    2 1
    Poland Sweden
  • A study of SAR448851 with FLORQUINITAU (18F) to assess safety and effectiveness in early Alzheimer’s disease

    Not yet recruiting

    2 1
    Investigated Drugs:
    Germany Spain
  • A Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Hungary Italy Poland +1
  • Phase 1/2 Study of ter-2013-01, imlunestrant, and fulvestrant in patients with solid tumors with AKT/PI3K/PTEN pathway alterations

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium France Hungary Ireland Poland Portugal +2
  • Safety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease

    Not yet recruiting

    3 1 1 1
    Finland Germany Greece Hungary Italy Poland +1
  • Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Estonia Finland Germany Lithuania The Netherlands +2
  • Rimonabant for Improving Walking Ability in Post‑Stroke Patients in the Chronic Phase

    Not yet recruiting

    2 1
    Investigated Diseases:
    Spain
  • Efficacy of Intravenous Lidocaine versus Sodium Chloride in Reducing Postoperative Pain for Patients Undergoing Emergency Abdominal Surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    France
  • Phase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy Poland +1

powered by